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Abstract In November 1975, as the first in the Nether-
lands, a full-time psychologist was employed at the
Department of Cardiology of the Thoraxcenter of the
Erasmus Medical Center. This innovative decision was
consistent with a view to treat the patient as a whole rather
than the heart as a single body part in need of repair,
combined with the understanding that the heart and mind
interact to affect health. The present selective review
addresses the broad range of contributions of 35 years of
psychology to clinical cardiology and cardiovascular
research with a focus on research, teaching, psychological
screening and patient care. The review ends with lessons to
be learned and challenges for the future with respect to
improving the care and management of patients with heart
disease in order to enhance secondary prevention and the
role of behavioural and psychological factors in this
endeavour.
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Introduction
Clinical treatment and understanding of medicine has
benefited greatly from the holistic view of the human
body [1]. In cardiology, major advances have been made
by examining the interactions between heart and mind—
that is to say, cardiovascular medicine entails the art of
medicine that understands disease as more than the sum of
its parts—which in essence reflects the bio-psychosocial
model that we know and use today. In November 1975,
as the first in the Netherlands, Professor Paul G.
Hugenholtz—Head of Cardiology at the Erasmus Med-
ical Center (MC) in Rotterdam—elected to employ a
full-time psychologist in the Department of Cardiology
of the Thoraxcenter. This innovative decision was
consistent with his view to treat the patient as a whole
rather than the heart as a single body part in need of
repair, combined with the understanding that the heart
and mind interact to affect health. This integrative
understanding of cardiology also gave rise to a practical
need for a standardised self-report questionnaire that
could provide cardiologists with quantifiable information
about the psychological well-being of cardiac patients.
As such, he could be considered a pioneer in behav-
ioural cardiology. The present selective review addresses
the broad range of contributions of 35 years of
psychology to clinical cardiology and cardiovascular
research in the Erasmus MC.
Cardiac psychology is the field of health psychology
that identifies psychosocial risk factors for the develop-
ment of cardiovascular illness and lifestyle changes that
may help prevent and heal heart disease. In this
selective review we address questions, including: Have
patients profited? Have cardiologists, nurses on the
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ward, and other healthcare professionals managing
cardiac patients benefited? Has it from a scientific point
of view led to groundbreaking results? What are the
lessons to be learned?
Research in the field of cardiac psychology
Over the past 35 years, research in the field of cardiac
psychology at the Erasmus MC has been diverse. A
selection of these investigations includes:
& Development and validation of psychological instru-
ments for specific groups of heart patients [2–4].
& Information provision for patients undergoing cardiac
surgery [5].
& Influence of early discharge of acute myocardial
infarction (MI) patients on psychological morbidity [6].
& Psychosocial and physical functioning after cardiac
rehabilitation [7].
& Psychological aspects of non-cardiac chest pain [8].
& Secondary prevention, multifactorial smoking cessation
programme in cardiac patients [9].
& Psychosocial aspects in patients with congenital heart
disease [10].
& Patient- and physician-related factors explaining the
delay prior to admission among acute myocardial
infarction patients [11].
& Effects of treating vital exhaustion in angioplasty
patients on new coronary events [12].
& The role of personality as a determinant of quality of
life in heart transplantation recipients [13].
& Web-based behavioural intervention in patients with an
implantable cardioverter defibrillator (ICD) [14].
& Risk of chronic anxiety in patients with an ICD [15].
& Psychological morbidity and quality of life in patients
with peripheral artery disease [16].
& Anxiety in partners of ICD patients and the role of
personality, shocks and ICD indication [17, 18].
& Influence of personality and psychological distress on
mortality in diverse groups of cardiac patients [19, 20].
Specific results deserve particular attention, since re-
search in these patient groups is still ongoing at the
Erasmus MC and because of their potential to influence
patient care. These results relate to the impact of heart
disease and treatment strategies on the emotional well-
being and quality of life of patients, and the influence of
psychological factors on morbidity and mortality. For this
end, we have chosen to reflect on the results of patients
with congenital heart disease and patients receiving state-
of-the-art treatment, such as percutaneous coronary inter-
vention (PCI) with drug-eluting stenting and ICD therapy.
These last two patient groups have been the focus of
cardiac psychology research in the Erasmus MC since 2001
and 2003, respectively.
& A cohort study of 498 patients 15 years or younger at
the time of surgical correction for congenital heart
disease performed between 1968 and 1980 at the
Erasmus MC and followed up for 10 years showed that
these patients displayed scores in the psychological,
deviant range compared with peers from a normative
reference group (27% versus 10%) [21]. A second
follow-up of 362 patients 20–46 years postsurgery
indicated that the congenital patients had measurable
impairments in their level of education, occupation, and
physical functioning. Predictors for long-term psycho-
pathology were female gender, low exercise capacity,
physical restrictions imposed by physicians, and the
level of patient-perceived restrictions imposed by the
scar following open heart surgery [22].
& In a consecutive cohort of 796 PCI patients treated with
drug-eluting stenting between February 2005 and
February 2006, 30.2% patients were depressed 4 weeks
post index event, as assessed with the 2-item Patient
Health Questionnaire (PHQ-2). Depressed patients had
an almost 2-fold increased risk of a non-fatal MI or
mortality at a mean follow-up period of 1.4 years
independent of their demographic and clinical risk
profile. When stratifying analyses by gender, depressive
symptoms were associated with a more than 2-fold
increased risk of adverse clinical events in men but not
in women [23].
& In a consecutive cohort of 371 patients implanted with
an ICD between August 2003 and December 2008, the
incidence of mortality was close to 3-fold higher in
those with a distressed (Type D) personality and 2-fold
higher in patients with high levels of ICD concerns
adjusting for demographic and clinical characteristics
including ICD shocks. Patients with clustering of both
Type D personality and high levels of pre-implantation
concerns (HR:3.86; 95%CI:1.64–9.10) had a close to 4-
fold increased risk of mortality compared with patients
with one or none of these risk markers in adjusted
analysis. ICD shocks during the follow-up period was
associated with a 3-fold risk of mortality [20].
Perhaps not surprisingly these results emphasise that
despite state-of-the art treatment with new innovative
techniques in clinical cardiology, after 35 years the
psychological profile of the patient still matters. More
importantly, psychological factors carry independent prog-
nostic value, irrespective of and adjusting statistically for
traditional biomedical risk factors, as also demonstrated by
others (see Pedersen et al. for a further overview of the role
of psychological factors in heart disease) [24]. Together
with other research findings in the field of cardiac
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psychology [19, 23, 25–27], these results indicate that it is
necessary to screen patients for psychological risk markers
in clinical cardiology practice, as neither this information
nor a proxy is available from the patients’ medical records.
The identification of this subset of high-risk patients would
allow further intervention including optimisation of medical
treatment but also adjunctive intervention of a psychosocial
and behavioural nature. Accordingly, in a recent advisory
the American Heart Association recommended that patients
with heart disease be screened standardly for depression [28].
However, this recommendation has led to an ardent debate in
the scientific community, since we do not know whether
early screening and detection leads to improved clinical
outcomes [29, 30]. Irrespectively, depression deserves
treatment in its own right due to its influence on quality of
life, patient well-being, and compliance, with standardised
and validated screening tools being available as are treatment
options to reduce the burden of depression [29].
Screening for psychological morbidity
In order to screen cardiac patients for psychological factors
in a standardised and valid fashion, it is important to use
validated and reliable instruments. This not only requires
knowledge of test development but also knowledge of the
procedures used to adapt into Dutch existing instruments
that were developed abroad, both of which form part of the
expertise of medical and clinical psychologists. Validation
of instruments in the Dutch setting developed in another
language is necessary, as there may be cross-cultural
differences such that a particular item in a scale may not
be relevant in a different language and cultural setting,
which might jeopardise the validity and reliability of the
entire instrument. Among others, in the Erasmus MC, we
have developed and/or validated the disease-specific instru-
ments the Heart Patients Psychological Questionnaire
(HPPQ) [4], the ICD Patient Concerns questionnaire [2],
the Minnesota Living with Heart Failure Questionnaire [3],
and the Peripheral Artery Questionnaire [31, 32]. These
instruments do not tap all psychological factors that have
been associated with increased risk of morbidity and
mortality in cardiac patients independent of traditional
biomedical risk factors.
The HPPQ—in Dutch known as the Medisch Psychologi-
sche Vragenlijst voor Hartpatiënten (MPVH)—is a disease-
specific measure that was developed in order to be able to
identify cardiac patients with psychological morbidity at an
early stage such that cardiologists can intervene and if
warranted refer the patient to a psychologist or another
mental health professional. The HPPQ comprises four
subscales tapping into patient well-being, feelings of being
disabled, despondency, and social inhibition. The scale was
validated in a mixed cohort of 1649 cardiac patients.
Research has shown that feelings of being disabled assessed
at the time of the index MI predict death 8–10 years post-MI
and also morbidity and mortality 4 years post-PCI indepen-
dent of traditional biomedical risk factors [33–35].
In 1998, the collaboration with Wijbenga and others led to
the translation and validation of the Minnesota Living with
Heart Failure Questionnaire in Dutch, enabling the identifica-
tion of patients with heart failure with poor quality of life [3].
Poor quality of life, as assessed with the Minnesota Living
with Heart Failure Questionnaire, has been shown to predict
mortality in heart failure patients [25].
Similarly, in 2005 we adapted and validated the ICD
Patient Concerns questionnaire (ICDC) to the Dutch setting
[2], which was developed in the UK to tap patient concerns
about the ICD giving a shock [36]. Recently, in a cohort of
ICD patients from the EMC, we have shown that patient
concerns, as assessed with the ICDC, predict mortality with
the associated odds being 2-fold [20].
With these developments at least two goals can be reached.
First, in the diagnosis and treatment of patients with heart
disease, the cardiologist has the opportunity to use disease-
specific self-report questionnaires representing the patient
perspective. Such screening allows for the early identification
of patients at high risk for cardiovascular morbidity and
mortality, but may also aid in clinical decision-making
pointing to patients who may need more aggressive or
adjunctive treatment [37]. Dependent on the patient’s
psychological profile, level of psychological morbidity, and
health status, it may be necessary to refer the patient to a
medical psychologist. This healthcare professional is knowl-
edgeable about heart disease, the impact of treatment options
(e.g. living with an ICD) on patients, but also how to treat
psychological morbidity taking into account the patient’s
social situation (e.g. not having a partner), such that the
intervention is tailored to the individual. Due to the
possibility of early intervention, this is not only likely to
improve patient care but also survival. Second, it makes for a
more complete and holistic approach to the clinical manage-
ment of patients with heart disease. With the information
provided by the questionnaires completed by patients, the
cardiologist will have a better understanding of the psycho-
logical profile of the patient, which is likely to enhance
patient-doctor communication, patient satisfaction and per-
haps even patient adherence with treatment advice. Psycho-
logical morbidity, such as depression, has been shown to
reduce adherence to cardiac rehabilitation and lifestyle
advice in cardiac patients [38].
Cardiac rehabilitation
The time when the benefits of cardiac rehabilitation still had to
be proven is luckily in the past. Today healthcare professionals
involved in the care and treatment of cardiac patients are
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increasingly recognising that an MI, bypass operation, heart
transplantation, or the receipt of one or multiple ICD shocks
may be associated with psychological consequences. In 1975
this was not the case, and scepticism towards cardiac
rehabilitation was pervasive across the country. Together with
the various Rehabilitation Committees of the Dutch Heart
Foundation, the Rotterdam rehabilitation programme Capri
served as a pioneer to promote cardiac rehabilitation.
Scientific publications on the usefulness and effect of
rehabilitation led to further evolvement of cardiac rehabilita-
tion programmes [7, 39, 40]. Today’s cardiac rehabilitation
comprises a series of modules, including physical training,
stress management, smoking cessation, dietary advice, and
relaxation therapy that are targeted towards the needs of the
individual patient. Following an acute cardiac event, cardiac
patients today have the possibility of receiving professional
assistance that is geared towards increasing physical activity
and exercise tolerance, dealing with feelings of anxiety and
depression, activating social support, and promoting social
re-integration [41]. This is a far cry from what was available
in 1975. Nevertheless, we are not quite there yet. So far, the
assumption has been that one size fits all, while there is an
indication that subsets of patients, such as women, older
patients, and depressed patients, may warrant specialised and
more individually tailored cardiac rehabilitation [42]. More-
over, there is a great disparity in the percentage of patients
attending cardiac rehabilitation across Europe and a large
number of patients who do not meet the lifestyle targets set
out for cardiovascular disease prevention [43].
Teaching
Interview techniques and patient-doctor communication
are, in our experience, not topics that the average
cardiologist tends to consciously think about on a daily
basis. Nevertheless, patient complaints lodged with the
complaints committee of hospitals tend to a great extent to
be attributable to poor patient-doctor communication,
commonly leaving the patient with a feeling of not being
listened to, misunderstood, and even mistreated. In order to
enhance the quality of the consultation between patient and
cardiologist, in the Erasmus MC at least one conversation
between the intern and the patient is recorded on camera
during the intern’s training and is discussed with a
psychologist (the first author). The intern will learn about
the basic do’s and don’ts of conversational techniques.
Don’ts include starting the consult with a detailed cardiac
history (usually serves to make the intern feel at ease),
using medical terminology unnecessarily, posing suggestive
questions, forcing a change in lifestyle (forcing does not
help), displaying no empathy in situations that are difficult
to the patient, writing down too much or looking at the
computer screen instead of maintaining the relation with the
patient by means of eye contact, forgetting to ask the
patient if he has any further questions or if something is not
clear at the end of the consult. When looking at the
recording together with the psychologist, the intern is
usually worried about potential criticism. However, it helps
to say that the consult with the psychologist is meant as a
learning opportunity and nothing else, and that the
recording and what will be discussed will remain confi-
dential. This instils in the intern a feeling of being in a safe
and protective setting, which in turn enhances openness and
facilitates discussion, while providing a way to learn from
one’s own mistakes and the possibility of becoming a better
doctor. Throughout his or her career - when dealing with
patients—the cardiologist is faced with the challenge of
keeping a balance between these softer sides of patient care
and the more technical aspects of clinical cardiology.
Patient care
Perhaps the most important remaining question is whether
patient care has improved as a result of the addition of a
psychologist to the interdisciplinary team managing patients
with heart disease? The answer to this question is not
straightforward, but the presence of such expertise makes it
possible for cardiologists and cardiovascular nurses to:
– Consult the psychologist if a patient is emotionally
distraught while admitted in the unit and needs
psychological counselling.
– Prior to discharge, refer the patient via the psycholo-
gist to a healthcare professional with the same expertise
in the area where the patient lives.
– Provide more optimal after care in the outpatient clinic
with a cardiac psychologist onboard who is knowl-
edgeable not only about psychological issues but also
the somatic condition, including the latest treatment
possibilities in clinical cardiology and the potential
impact of such treatments on the patient.
In addition, the expertise of the psychologist may exert
its influence on patient care in more subtle and indirect
ways that are not necessarily visible or consciously
acknowledged in daily clinical practice. From that point
of view all of the aspects discussed here are woven together
and form more than the sum of their parts in terms of
improving the quality of patient care (Fig. 1).
Cardiac psychology—future challenges
Despite the progress made in the field of cardiac psychol-
ogy since the decision to employ a full-time psychologist at
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the Department of Cardiology in the Erasmus MC 35 years
ago, there are several imminent challenges that need
clinical and scientific attention, which are outlined in
Table 1.
In essence all of these challenges relate to the inclusion
of the patient perspective (i.e., asking the patient to rate
how he or she feels) in the care and management of patients
with heart disease with the objective of enhancing the
quality of care that we give to patients. The value of
behavioural and psychological factors was recognised by
the European Society of Cardiology guidelines on cardio-
vascular disease prevention in 2003 [46]. Continued efforts
Fig. 1 The role of the psychol-
ogist in improving the quality
of patient care
Table 1 Challenges ahead for the field of cardiac psychology that may help enhance the quality of patient care
Challenge Rationale
• Incorporating screening for
psychological risk markers and
health status as part of standard
clinical practice
• Psychological factors and health status predict prognosis independent of traditional biomedical risk
factors [20, 25, 44] and cannot be derived from other proxy measures available in clinical practice
• The incorporation of patient-reported health status in clinical practice can help in treatment decision-
making [45] and health status can be used as a performance measure of the quality of care [37]
• In 2003, behavioural and psychological factors were introduced for the first time in the official
European guidelines on cardiovascular disease prevention [46], but little has changed in clinical practice
• Development and improvement of
disease-specific self-report
questionnaires
• These measures aid to identify vulnerable and high-risk patients in clinical research and practice [29]
• Implementation and fine-tuning
of behavioural interventions
• Evidence from large-scale intervention trials targeting depression is mixed with respect to influencing
prognosis [47]
• The assumption that one size fits all and that we are able to influence cardiovascular endpoints might
be some of the explanations for the failure of these trials, with stepped collaborative care being more
successful [29, 48]
• Further enhancement of secondary
prevention programmes, such as
cardiac rehabilitation
• Cardiac rehabilitation is an effective means to reduce morbidity and mortality
• However, there is an indication that one size fits all does not hold, with subsets of patients, such as
women, older patients, and depressed patients, warranting specialised and more individually tailored
cardiac rehabilitation [42]
• There is a great disparity in the percentage of patients attending cardiac rehabilitation across Europe
[49] and a large number of patients who do not meet the lifestyle targets set out for cardiovascular
disease prevention [43]
• Development of genetic counselling
programmes for patients and their
families with a risk of familiar
heart disease
• Screening, waiting for and learning of the outcome may lead to distress in subsets of patients [50]
• No such programmes are currently available for patients and their families at the cardiology department
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need to be made to increase the incorporation of these
psychosocial factors in clinical practice. For example,
consider how a patient would feel if he/she had heart
disease and knew that being depressed would influence
prognosis, would that patient not want to be screened for
depression similar to screening for ‘traditional risk factors’
such as blood pressure, cholesterol levels, and blood
glucose levels? Ignorance may be bliss, but knowing about
the patient’s psychological risk profile would provide the
opportunities for integrative interventions and care. Already
35 years ago, the importance of the psychological profile of
the patient in recovery and disease progression was
recognised; the time now seems ripe for implementing
what we have learnt to optimise cardiovascular care,
particularly in high-risk patients. The major challenge for
the future lies in the implementation of early psychological
screening and assessment of behavioural and emotional
problems, and treatment of these problems in cardiac
patients, in particular with respect to availability of the
necessary infrastructure, logistics, and staff.
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